Root Admin Guide Posted September 17, 2017 Root Admin Report Share Posted September 17, 2017 "...the results of a pooled analysis of four Galderma-sponsored studies evaluating the use of topical therapies for the treatment of inflammatory papules and pustules of rosacea were presented at the 26th European Academy of Dermatology and Venereology Congress in Geneva, Switzerland. The success of rosacea treatment is usually defined as a score of 1 ('almost clear') or 0 ('clear') on the 5-point Investigator Global Assessment (IGA) scale. The new analysis reports that rosacea patients who achieve 'clear' (IGA 0), not only experience a more complete reduction in inflammatory lesions compared with patients who achieve 'almost clear' (IGA 1), but also an extended time to relapse that is associated with improved quality of life." ‘CLEAR’ (IGA 0) ROSACEA PATIENTS EXPERIENCE A DELAYED TIME TO RELAPSE, Lausanne, Switzerland – September 16, 2017 Galderma: 'Clear' (IGA 0) Rosacea Patients Experience a Delayed Time to Relapse PR Newswire Sep. 16, 2017 Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now